Evidence map›Paper›PMID 34960986›Full record

ArticlePolymers2021

Improvement of Properties and Performances of Polyethersulfone Ultrafiltration Membrane by Blending with Bio-Based Dragonbloodin Resin.

Aulia Chintia Ambarita, Sri Mulyati, Nasrul Arahman, Muhammad Roil Bilad, Norazanita Shamsuddin, Noor Maizura Ismail

Abstract read
In one paragraph

Article in Polymers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aulia Chintia AmbaritaDoctoral Program, School of Engineering Science, Syiah Kuala University, Banda Aceh 23111, Indonesia.
Sri MulyatiDepartment of Chemical Engineering, Syiah Kuala University, Banda Aceh 23111, Indonesia.ORCID 0000-0001-5865-4769
Nasrul ArahmanDepartment of Chemical Engineering, Syiah Kuala University, Banda Aceh 23111, Indonesia.ORCID 0000-0001-5077-2867
Muhammad Roil BiladFaculty of Integrated Technologies, Universiti Brunei Darussalam, Bandar Seri Begawan BE1410, Brunei.ORCID 0000-0001-7292-6046
Norazanita ShamsuddinFaculty of Integrated Technologies, Universiti Brunei Darussalam, Bandar Seri Begawan BE1410, Brunei.
Noor Maizura IsmailFaculty of Engineering, Universiti Malaysia Sabah, Kota Kinabalu 88400, Sabah, Malaysia.ORCID 0000-0002-4469-0993

Funding

Syiah Kuala University PRUU-PD
6 · The paper itself

Abstract

Polyethersulfone (PES) is the most commonly used polymer for membrane ultrafiltration because of its superior properties. However, it is hydrophobic, as such susceptible to fouling and low permeation rate. This study proposes a novel bio-based additive of dragonbloodin resin (DBR) for improving the properties and performance of PES-based membranes. Four flat sheet membranes were prepared by varying the concentration of DBR (0-3%) in the dope solutions using the phase inversion method. After fabrication, the membranes were thoroughly characterized and were tested for filtration of humic acid solution to investigate the effect of DBR loading. Results showed that the hydrophilicity, porosity, and water uptake increased along with the DBR loadings. The presence of DBR in the dope solution fastened the phase inversion, leading to a more porous microstructure, resulted in membranes with higher number and larger pore sizes. Those properties led to more superior hydraulic performances. The PES membranes loaded with DBR reached a clean water flux of 246.79 L/(m

Indexed as

antifoulingbio-based additivedragonbloodinpolyethersulfoneultrafiltration

Identifiers

PMID34960986
PMCPMC8707211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.